Prevalence of Coronary Microvascular Dysfunction and Epicardial Spasm in Patients With Angina and Myocardial Bridge

Overview

Journal J Soc Cardiovasc Angiogr Interv

Specialty Cardiology & Vascular Diseases

Date 2024 Nov 22

PMID 39575216

Authors

Tess E Allan

Michael M Mayer

Steven E S Miner

Hena Patel

Amit R Patel

Husam H Balkhy

Jonathan D Paul

Atman P Shah

Sandeep Nathan

John E A Blair

Affiliations

Soon will be listed here.

Abstract

Background: Myocardial bridges (MB) are prevalent but not universally associated with angina. The mechanisms linking MB and angina are poorly defined. The objective of this study was to determine the prevalence of epicardial spasm, microvascular spasm, and/or endothelium-independent coronary microvascular dysfunction (CMD) in patients with MB which might explain symptoms.

Methods: Patients with known MB and chest pain at the University of Chicago Medical Center between 2020-2023 were included. All patients underwent dobutamine testing with measurement of resting full-cycle ratio to determine hemodynamic significance (resting full-cycle ratio ≤0.76). Endothelium-independent CMD was defined as coronary flow reserve <2.0 or index of microvascular resistance ≥25 on adenosine testing. Microvascular spasm was defined as chest pain and electrocardiogram changes with nonischemic fractional flow reserve with acetylcholine. Epicardial spasm was defined as dynamic stenosis of >90% of the epicardial vessel or ischemic fractional flow reserve (≤0.8) with acetylcholine.

Results: A total of 30 patients (mean age, 47 ± 10 years; 60% female) with MB were studied. Endothelium-independent CMD, microvascular spasm, and epicardial spasm occurred commonly in 60%, 29%, and 37% of patients respectively, with 77% having at least one abnormality. The MB was hemodynamically significant in 47% of patients, and the prevalence of these coexisting conditions was not affected by hemodynamic significance.

Conclusions: Epicardial spasm, microvascular spasm, and endothelium-independent CMD are prevalent in patients presenting with known MB and chest pain irrespective of the hemodynamic significance of the bridge. Invasive coronary function testing may play an important role in uncovering alternative explanations for angina in patients with known MB.

References

Lee S, Shin D, Lee J, van de Hoef T, Hong D, Choi K . Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction. J Am Heart Assoc. 2022; 11(9):e025171. PMC: 9238617. DOI: 10.1161/JAHA.121.025171. View

Nam P, Choi B, Choi S, Byun J, Mashaly A, Park Y . The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis. Atherosclerosis. 2018; 270:8-12. DOI: 10.1016/j.atherosclerosis.2018.01.026. View

Escaned J, Cortes J, Flores A, Goicolea J, Alfonso F, Hernandez R . Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging. J Am Coll Cardiol. 2003; 42(2):226-33. DOI: 10.1016/s0735-1097(03)00588-6. View

Hostiuc S, Negoi I, Rusu M, Hostiuc M . Myocardial Bridging: A Meta-Analysis of Prevalence. J Forensic Sci. 2017; 63(4):1176-1185. DOI: 10.1111/1556-4029.13665. View

Pargaonkar V, Kimura T, Kameda R, Tanaka S, Yamada R, Schwartz J . Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease. EuroIntervention. 2020; 16(13):1070-1078. PMC: 9725037. DOI: 10.4244/EIJ-D-20-00779. View

Lee B, Lim H, Fearon W, Yong A, Yamada R, Tanaka S . Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015; 131(12):1054-60. PMC: 5295466. DOI: 10.1161/CIRCULATIONAHA.114.012636. View

Kunadian V, Chieffo A, Camici P, Berry C, Escaned J, Maas A . An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders.... Eur Heart J. 2020; 41(37):3504-3520. PMC: 7577516. DOI: 10.1093/eurheartj/ehaa503. View

Masuda T, Ishikawa Y, Akasaka Y, Itoh K, Kiguchi H, Ishii T . The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization. J Pathol. 2001; 193(3):408-14. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH792>3.0.CO;2-R. View

Tang K, Wang L, Shi R, Zheng X, Li T, Zhao X . The role of myocardial perfusion imaging in evaluating patients with myocardial bridging. J Nucl Cardiol. 2010; 18(1):117-22. DOI: 10.1007/s12350-010-9303-6. View

10.

Nardone M, McCarthy M, Ardern C, Edgell H, Toleva O, Nield L . Characterization of the Human Coronary Microvascular Response to Multiple Hyperaemic Agents. CJC Open. 2021; 3(2):133-141. PMC: 7893196. DOI: 10.1016/j.cjco.2020.09.017. View

11.

Medina F, Estrada A, Fernandez C, Balkhy H, Kim G, Shah A . Use of Intravascular Ultrasound and Coronary Angiography to Measure the Prevalence of Myocardial Bridge in Heart Transplant Patients. Am J Cardiol. 2023; 205:176-181. DOI: 10.1016/j.amjcard.2023.07.173. View

12.

Taqueti V, Shaw L, Cook N, Murthy V, Shah N, Foster C . Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2016; 135(6):566-577. PMC: 5459611. DOI: 10.1161/CIRCULATIONAHA.116.023266. View

13.

Tarantini G, Barioli A, Fovino L, Fraccaro C, Masiero G, Iliceto S . Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation. Circ Cardiovasc Interv. 2018; 11(6):e006247. DOI: 10.1161/CIRCINTERVENTIONS.117.006247. View

14.

Sara J, Widmer R, Matsuzawa Y, Lennon R, Lerman L, Lerman A . Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. JACC Cardiovasc Interv. 2015; 8(11):1445-1453. DOI: 10.1016/j.jcin.2015.06.017. View

15.

Mirzai S, Patel B, Balkhy H . Robotic totally endoscopic off-pump unroofing of left anterior descending coronary artery myocardial bridge: A report of two cases. J Card Surg. 2019; 34(8):735-737. DOI: 10.1111/jocs.14094. View

16.

Hemmati P, Schaff H, Dearani J, Daly R, Lahr B, Lerman A . Clinical Outcomes of Surgical Unroofing of Myocardial Bridging in Symptomatic Patients. Ann Thorac Surg. 2019; 109(2):452-457. DOI: 10.1016/j.athoracsur.2019.07.005. View

17.

Abe M, Tomiyama H, Yoshida H, Doba N . Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses: comparison with fractional flow reserve and coronary flow velocity reserve. Circulation. 2000; 102(19):2365-70. DOI: 10.1161/01.cir.102.19.2365. View

18.

Boyd J, Pargaonkar V, Scoville D, Rogers I, Kimura T, Tanaka S . Surgical Unroofing of Hemodynamically Significant Left Anterior Descending Myocardial Bridges. Ann Thorac Surg. 2016; 103(5):1443-1450. DOI: 10.1016/j.athoracsur.2016.08.035. View

19.

Aleksandric S, Djordjevic-Dikic A, Dobric M, Giga V, Soldatovic I, Vukcevic V . Functional Assessment of Myocardial Bridging With Conventional and Diastolic Fractional Flow Reserve: Vasodilator Versus Inotropic Provocation. J Am Heart Assoc. 2021; 10(13):e020597. PMC: 8403296. DOI: 10.1161/JAHA.120.020597. View

20.

Dryer K, Gajjar M, Narang N, Lee M, Paul J, Shah A . Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018; 314(5):H1033-H1042. PMC: 6008137. DOI: 10.1152/ajpheart.00680.2017. View